Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome.
A review of 950 patients was performed to investigate the impact of selective serotonin reuptake inhibitors (SSRIs) on in vitro fertilization outcome. The 41 patients (4.3%) taking an SSRI had a higher cycle cancellation rate but no statistically significant difference in pregnancy rate and live birth rate per cycle started.
Friedman
Brooke E
BE
Stanford Fertility and Reproductive Medicine Center, Palo Alto, California. Electronic address: brookef1@stanford.edu.
Rogers
Jayna L
JL
Stanford Fertility and Reproductive Medicine Center, Palo Alto, California.
Shahine
Lora K
LK
Stanford Fertility and Reproductive Medicine Center, Palo Alto, California.
Westphal
Lynn M
LM
Stanford Fertility and Reproductive Medicine Center, Palo Alto, California.
Lathi
Ruth B
RB
Stanford Fertility and Reproductive Medicine Center, Palo Alto, California.
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use; D001071:Appointments and Schedules; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D005298:Fertility / Q000187:drug effects* / Q000502:physiology; D005307:Fertilization in Vitro / Q000379:methods; D006801:Humans; D007246:Infertility / Q000150:complications / Q000453:epidemiology / Q000628:therapy; D050498:Live Birth; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D018873:Pregnancy Rate; D012189:Retrospective Studies; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors